Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?

Overview of attention for article published in Hepatic medicine evidence and research, April 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Ser235 phosphorylation of hepatitis C virus NS5A is required for NS5A dimerization and drug resistance

Article in Life Sciences (December 2023)

Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection

Book chapter (January 2017)

Chapter 38 Personalized Medicine for Hepatitis C Virus

Book chapter (January 2017)